STOCK TITAN

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Maravai LifeSciences, Inc. (NASDAQ: MRVI) is set to release its fourth quarter and full year 2022 financial results on February 22, 2023. The announcement will occur after the market closes, followed by a conference call at 2:00 p.m. PT/5:00 p.m. ET. Investors can join the call via telephone or through a live and archived webcast available on the company’s investor website. As a leading provider of life science reagents, Maravai supports research and development in drug therapies, diagnostics, and vaccines, catering to top biopharmaceutical and gene therapy firms.

Positive
  • Scheduled announcement of fourth quarter and full year 2022 results indicates transparency to investors.
  • Presence in the critical life sciences sector with a focus on drug therapies and diagnostics.
Negative
  • None.

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2022 financial and operating results after the market closes on Wednesday, February 22, 2023, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial (877) 315-3037 or (201) 689-8357 and reference Maravai LifeSciences. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.


FAQ

When will Maravai LifeSciences announce its Q4 and full year 2022 results?

Maravai LifeSciences will announce its Q4 and full year 2022 results on February 22, 2023, after market close.

What time is the Maravai LifeSciences conference call?

The conference call for Maravai LifeSciences is scheduled for 2:00 p.m. PT/5:00 p.m. ET on February 22, 2023.

How can I access the Maravai LifeSciences earnings call?

You can access the Maravai LifeSciences earnings call by dialing (877) 315-3037 or (201) 689-8357, or via the live and archived webcast on their investor website.

What does Maravai LifeSciences specialize in?

Maravai LifeSciences specializes in providing reagents and services for drug therapies, diagnostics, and vaccines, focusing on nucleic acid synthesis and biologics safety testing.

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

776.59M
119.61M
1.37%
102.83%
4.91%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN DIEGO